within Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopicalUse.R01AB07_Oxymetazoline;

model Oxymetazoline
  extends Pharmacolibrary.Drugs.ATC.R.R01AB07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R01AB07</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxymetazoline is a direct-acting alpha-adrenergic agonist primarily used as a topical decongestant for temporary relief of nasal congestion due to colds, allergies, or sinusitis. It is commonly found in over-the-counter nasal spray products. Oxymetazoline is approved and widely used today for short-term relief.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for oxymetazoline after intranasal administration in healthy adult volunteers. No population-specific differences (sex, age, or disease conditions) were reported.</p><h4>References</h4><ol><li><p>Giannakopoulos, H, et al., &amp; Hersh, EV (2012). The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings. <i>Journal of the American Dental Association (1939)</i> 143(8) 872–880. DOI:<a href=\"https://doi.org/10.14219/jada.archive.2012.0291\">10.14219/jada.archive.2012.0291</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22855901/\">https://pubmed.ncbi.nlm.nih.gov/22855901</a></p></li><li><p>Cacek, AT, et al., &amp; Gopalakrishnan, M (2017). Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers. <i>Journal of clinical pharmacology</i> 57(2) 247–254. DOI:<a href=\"https://doi.org/10.1002/jcph.799\">10.1002/jcph.799</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27436060/\">https://pubmed.ncbi.nlm.nih.gov/27436060</a></p></li><li><p>Hersh, EV, et al., &amp; Moore, PA (2016). Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles. <i>Current medical research and opinion</i> 32(11) 1919–1925. DOI:<a href=\"https://doi.org/10.1080/03007995.2016.1238352\">10.1080/03007995.2016.1238352</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27646144/\">https://pubmed.ncbi.nlm.nih.gov/27646144</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Oxymetazoline;
